Saluda Medical Announces Presentation of New Clinical Data at the 2025 NANS Annual Meeting

Presentations Included First Human Data on EVA™, Saluda’s Automated SCS Programming Platform MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ — Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.